SF grows client assets by 7% and fee-based assets by 11% y/y in April, which have been steady despite equity market volatility.

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming ...